This document is an excerpt from the EUR-Lex website
Document 62020TN0635
Case T-635/20: Action brought on 21 October 2020 — Dermavita Company v EUIPO — Allergan Holdings France (JUVÉDERM VYBRANCE)
Case T-635/20: Action brought on 21 October 2020 — Dermavita Company v EUIPO — Allergan Holdings France (JUVÉDERM VYBRANCE)
Case T-635/20: Action brought on 21 October 2020 — Dermavita Company v EUIPO — Allergan Holdings France (JUVÉDERM VYBRANCE)
OJ C 443, 21.12.2020, p. 25–26
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
21.12.2020 |
EN |
Official Journal of the European Union |
C 443/25 |
Action brought on 21 October 2020 — Dermavita Company v EUIPO — Allergan Holdings France (JUVÉDERM VYBRANCE)
(Case T-635/20)
(2020/C 443/29)
Language of the case: English
Parties
Applicant: Dermavita Company SARL (Beirut, Lebanon) (represented by: D. Todorov, lawyer)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Allergan Holdings France SAS (Courbevoie, France)
Details of the proceedings before EUIPO
Proprietor of the trade mark at issue: Other party to the proceedings before the Board of Appeal
Trade mark at issue: European Union word mark JUVÉDERM VYBRANCE –European Union trade mark No 13 541 594
Procedure before EUIPO: Cancellation proceedings
Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 24 August 2020 in Case R 1014/2020-4
Form of order sought
The applicant claims that the Court should:
|
— |
annul the contested decision; |
|
— |
ask EUIPO to deem the appeal filed; |
|
— |
order EUIPO and the other party to bear their own costs and pay those of the Applicant before the General Court. |
Plea in law
|
— |
Infringement of Articles 101(4), 104, 106 and 107 of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |